Company
Bafna Pharmaceuticals Ltd
Headquarters: Chennai, India
Employees: 288
Market Cap
₹2.36 Billion
INR as of Jan. 1, 2024
US$28.4 Million
Bafna Pharmaceuticals Ltd Categories
India Healthcare Drug Manufacturers—Specialty & GenericIndia Healthcare India Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Bafna Pharmaceuticals Limited manufactures and sells generic pharmaceutical products and finished pharmaceutical formulations in India. It also exports its products. The company was founded in 1981 and is based in Chennai, India.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Bafna Pharmaceuticals Ltd has the following listings and related stock indices.
Stock: NSE: BAFNAPH wb_incandescent
Stock: BSE: BAFNAPHARM wb_incandescent